Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 0.25%
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.25%;0.0091M...DOSAGE - INJECTABLE;INJECTION - 0.25%;0.0091MG/ML
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.5%
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG...DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.75%
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.75%;0.0091M...DOSAGE - INJECTABLE;INJECTION - 0.75%;0.0091MG/ML
USFDA APPLICATION NUMBER - 16964
DOSAGE - INJECTABLE;INJECTION - 0.25%
USFDA APPLICATION NUMBER - 18304
DOSAGE - INJECTABLE;INJECTION - 0.5%
USFDA APPLICATION NUMBER - 18304
DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG...DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
USFDA APPLICATION NUMBER - 18304
DOSAGE - INJECTABLE;INJECTION - 0.75%
USFDA APPLICATION NUMBER - 18304
DOSAGE - INJECTABLE;INJECTION - 0.75%;0.0091M...DOSAGE - INJECTABLE;INJECTION - 0.75%;0.0091MG/ML
USFDA APPLICATION NUMBER - 18304
DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG...DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
USFDA APPLICATION NUMBER - 22046
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Fillers, Diluents & Binders
Thickeners and Stabilizers
Topical
Taste Masking
Film Formers & Plasticizers
Chewable & Orodispersible Aids
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Bupivacaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bupivacaine Hydrochloride manufacturer or Bupivacaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bupivacaine Hydrochloride manufacturer or Bupivacaine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Bupivacaine Hydrochloride API Price utilized in the formulation of products. Bupivacaine Hydrochloride API Price is not always fixed or binding as the Bupivacaine Hydrochloride Price is obtained through a variety of data sources. The Bupivacaine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CS-2505 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CS-2505, including repackagers and relabelers. The FDA regulates CS-2505 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CS-2505 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CS-2505 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CS-2505 supplier is an individual or a company that provides CS-2505 active pharmaceutical ingredient (API) or CS-2505 finished formulations upon request. The CS-2505 suppliers may include CS-2505 API manufacturers, exporters, distributors and traders.
click here to find a list of CS-2505 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CS-2505 DMF (Drug Master File) is a document detailing the whole manufacturing process of CS-2505 active pharmaceutical ingredient (API) in detail. Different forms of CS-2505 DMFs exist exist since differing nations have different regulations, such as CS-2505 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CS-2505 DMF submitted to regulatory agencies in the US is known as a USDMF. CS-2505 USDMF includes data on CS-2505's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CS-2505 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CS-2505 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CS-2505 Drug Master File in Japan (CS-2505 JDMF) empowers CS-2505 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CS-2505 JDMF during the approval evaluation for pharmaceutical products. At the time of CS-2505 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CS-2505 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CS-2505 Drug Master File in Korea (CS-2505 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CS-2505. The MFDS reviews the CS-2505 KDMF as part of the drug registration process and uses the information provided in the CS-2505 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CS-2505 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CS-2505 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CS-2505 suppliers with KDMF on PharmaCompass.
A CS-2505 CEP of the European Pharmacopoeia monograph is often referred to as a CS-2505 Certificate of Suitability (COS). The purpose of a CS-2505 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CS-2505 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CS-2505 to their clients by showing that a CS-2505 CEP has been issued for it. The manufacturer submits a CS-2505 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CS-2505 CEP holder for the record. Additionally, the data presented in the CS-2505 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CS-2505 DMF.
A CS-2505 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CS-2505 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CS-2505 suppliers with CEP (COS) on PharmaCompass.
A CS-2505 written confirmation (CS-2505 WC) is an official document issued by a regulatory agency to a CS-2505 manufacturer, verifying that the manufacturing facility of a CS-2505 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CS-2505 APIs or CS-2505 finished pharmaceutical products to another nation, regulatory agencies frequently require a CS-2505 WC (written confirmation) as part of the regulatory process.
click here to find a list of CS-2505 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CS-2505 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CS-2505 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CS-2505 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CS-2505 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CS-2505 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CS-2505 suppliers with NDC on PharmaCompass.
CS-2505 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CS-2505 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CS-2505 GMP manufacturer or CS-2505 GMP API supplier for your needs.
A CS-2505 CoA (Certificate of Analysis) is a formal document that attests to CS-2505's compliance with CS-2505 specifications and serves as a tool for batch-level quality control.
CS-2505 CoA mostly includes findings from lab analyses of a specific batch. For each CS-2505 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CS-2505 may be tested according to a variety of international standards, such as European Pharmacopoeia (CS-2505 EP), CS-2505 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CS-2505 USP).
